Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
Identificadores
Identificadores
Data de publicación
2015Título da revista
DIGESTIVE DISEASES AND SCIENCES
Tipo de contido
Artigo